Hospitalized COVID-19 patients who took spirulina had a lower risk of death than those who did not, according to the results of a randomized controlled trial recently published in Frontiers in Immunology.
Study participants took spirulina for six days. No deaths were recorded in the spirulina group, while 15 percent of those who only received standard treatment died.





